Pyridostigmine bromide and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is reported as a side effect among people who take Pyridostigmine bromide (pyridostigmine bromide), especially for people who are male, 60+ old, also take Nuplazid, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hallucinations when taking Pyridostigmine bromide. It is created by eHealthMe based on reports of 1,857 people who have side effects when taking Pyridostigmine bromide from the FDA, and is updated regularly.

What is Pyridostigmine bromide?

Pyridostigmine bromide has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 1,948 Pyridostigmine bromide users. Check the latest studies of Pyridostigmine bromide.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,894 drugs and 2,728 conditions by eHealthMe. Check the latest studies of Hallucinations.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

1,857 people reported to have side effects when taking Pyridostigmine bromide.
Among them, 28 people (1.51%) have Hallucinations.

Could Pyridostigmine bromide cause Hallucinations?

Among these 28 people:

What is the gender of people who have Hallucinations when taking Pyridostigmine bromide? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Hallucinations when taking Pyridostigmine bromide? *

What are other drugs people take besides Pyridostigmine bromide? *

What are other side effects people have besides Hallucinations? *

Drowsiness: 13 people, 46.43%
Fatigue (feeling of tiredness): 9 people, 32.14%
Unresponsive To Stimuli: 8 people, 28.57%
Delirium (wild excitement): 7 people, 25.00%
Confusional State: 7 people, 25.00%
Stupor (lack of critical cognitive function and level of consciousness): 6 people, 21.43%
Intestinal Obstruction: 6 people, 21.43%
Skin Disorder (skin disease): 6 people, 21.43%
Abdominal Distension: 6 people, 21.43%
Swallowing Difficulty: 6 people, 21.43%

What are the existing conditions these people have? *

Parkinson's Disease: 18 people, 64.29%
Delusion (a false belief or opinion): 13 people, 46.43%
Insomnia (sleeplessness): 9 people, 32.14%
Dementia (madness): 7 people, 25.00%
Sleep Disorder: 6 people, 21.43%
Skin Disorder (skin disease): 6 people, 21.43%
Rash - Child Under 2 Years: 6 people, 21.43%
Psychotic Disorder: 6 people, 21.43%
Osteoporosis (bones weak and more likely to break): 6 people, 21.43%
Enlarged Prostate: 6 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Pyridostigmine bromide and have Hallucinations?

- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pyridostigmine bromide:

Pyridostigmine bromide (1,948 reports)

Hallucinations treatments and more:

Hallucinations (98,683 reports)

Browse all side effects of Pyridostigmine bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations:

Hallucinations (1,894 drugs)

Browse all the conditions that are associated with Hallucinations:

Hallucinations (2,728 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on pyridostigmine bromide (the active ingredients of Pyridostigmine bromide) and Pyridostigmine bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.